Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 219.00
Bid: 218.00
Ask: 219.00
Change: 5.00 (2.34%)
Spread: 1.00 (0.459%)
Open: 214.00
High: 224.50
Low: 214.00
Prev. Close: 214.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angus in Balcombe blow; YouGov buys Canada asset

Tue, 02nd Mar 2021 19:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Angus Energy PLC - UK-focused onshore oil and gas development company - Notes West Sussex County Council's Planning Committee rejects planning application for an extended well test at Balcombe oil field. Angus says "disappointed" by decision. "The company is presently evaluating all of the options available with its partners," Angus adds.

----------

YouGov PLC - London-based research data and analytics group - Buys Toronto-based sports research and consulting agency Charlton Insights, boosting YouGov Sport's presence in Canada. Acquisition fee is tied to a "three year earn-out", YouGov adds.

----------

CloudCall Group PLC - Leicester, England-based provider of unified communications and contact centre software - Receives additional demand so boosts size of fundraising to GBP7.5 million, from GBP7.0 million. Equity raise consists of 8.8 million placing shares and 357,169 shares as part of PrimaryBid offer.

----------

Next Fifteen Communications Group PLC - London-based digital communication group - To repay GBP1.4 million in furlough money from UK government amid "continued strong trading performance".

----------

FastForward Innovations Ltd - technology and life sciences sector focused investor - Notes 2.3% owned investee EMMAC Life Sciences sells wellness brands to Yooma Wellness Inc. FastForward has a 9.0% stake in Yooma.

----------

Vela Technologies PLC - Bingley, England-based company with investments in early-stage disruptive technology businesses - Invests roughly GBP66,000 in Mode Global Holdings PLC, as part of the London-listed fintech firm's GBP6 million placing.

----------

Warehouse REIT PLC - real estate investment trust focused on warehouse assets - Buys multi-let warehouse estate on Glasgow Airport Business Park for GBP5.3 million, representing net initial yield of 6.3%. "The property generates a net rental income of GBP357,000 per annum," Warehouse REIT adds.

----------

600 Group PLC - West Yorkshire, England-based manufacturer and distributor of machine tools, precision engineered components and industrial laser systems - Says three US operations granted forgiveness of initial loans under US government's Paycheck Protection Program. Loans amount to USD2.2 million. "Second round funding under the PPP scheme for an additional USD2.2 million has been applied for. From this application, two of the three entities have so far received their allocation, amounting to USD1.6 million, with the remaining USD600,000 expected to be received in the coming weeks," 600 adds. Notes order intake has continued to improve since first Covid-19 outbreak, with February up about 40% annually.

----------

Coral Products PLC - Merseyside-based supplier of injection moulded plastic products - Completes disposal of Coral Product (Mouldings) Ltd and Interpack Ltd to One51 ES Plastics UK Ltd for GBP7.9 million. Notes as planned, Chief Executive Officer Michael Wood steps down following disposals. Non-Executive Chair Joseph Grimmond becomes executive chair.

----------

Omega Diagnostics Group PLC - sells wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics market - Lands contract with Screen4 Ltd to provide Covid-19 antibody laboratory-based testing services.

----------

Quadrise Fuels International PLC - London-based fuel conversion technology firm - Raises GBP6.0 million from placing of 222.2 million shares at 2.7 pence each.

----------

PureTech Health PLC- Boston, Massachusetts-based biotherapeutics company - Founded entity Karuna Therapeutics, a firm developing medicines for psychiatric and neurological conditions, prices offer of 2.1 million shares at USD120.00 each. To raise about USD250.0 million.

----------

Castillo Copper Ltd - Australia and Zambia focused base metal explorer - Earmarks "strategic intent" to progress Big One deposit, Australia following " a series of excellent assay results" and global demand for copper. Castillo adds: "Further work is planned to extend known mineralisation and Big One deposit's potential scale, commencing with an induced polarisation survey to identify incremental test-drill targets."

----------

88 Energy Ltd - Alaska-focused oil producer - Says mobilisation of rig 111 to Merlin-1 location "progressing well" but reports "minor delays" attributed to weather. Spud date scheduled for March 8.

----------

Serabi Gold PLC - Brazil-focused gold miner - Raises USD17.5 million, about GBP12.5 million, from placing of 16.7 million shares at GBP0.75 each. "The financing completed today creates a strong financial position for Serabi from which we will be able to advance our significant growth opportunities," CEO Mike Hodgson says.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more
11 Jul 2022 19:15

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2022 21:50

IN BRIEF: PureTech Health begins pulmonary fibrosis study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.